News
12-07-2010, 12:21 AM
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it has secured an exclusive worldwide license from Bioclassifier, LLC to develop in vitro diagnostic and research products for breast cancer intrinsic subtyping.
More... (http://www.news-medical.net/news/20101207/NanoString-secures-exclusive-worldwide-license-to-develop-products-for-breast-cancer-intrinsic-subtyping.aspx)
More... (http://www.news-medical.net/news/20101207/NanoString-secures-exclusive-worldwide-license-to-develop-products-for-breast-cancer-intrinsic-subtyping.aspx)